Authors: Valerian L. Altersberger; Lotte J. Stolze; Mirjam R. Heldner; Hilde Henon; Nicolas Martinez-Majander; Christian Hametner; Annika Nordanstig; Andrea Zini; Stefania Nannoni; Bruno Gonçalves; Christian H. Nolte; Philipp Baumgartner; Andreas Kastrup; Panagiotis Papanagiotou; Georg Kägi; Ronen R. Leker; Marialuisa Zedde; Alessandro Padovani; Alessandro Pezzini; Visnja Padjen; Carlo W. Cereda; Georges Ntaios; Leo H. Bonati; Leon A. Rinkel; Urs Fischer; Jan F. Scheitz; Susanne Wegener; Guillaume Turc; Patrik Michel; Mauro Gentile; Alexandros Rentzos; Peter A. Ringleb; Sami Curtze; Charlotte Cordonnier; Marcel Arnold; Paul J. Nederkoorn; Stefan T. Engelter; Henrik Gensicke

Venue: Stroke

Type: Publication

Abstract: Background and Purpose: Timely reperfusion is an important goal in treatment of eligible patients with acute ischemic stroke. However, during the coronavirus disease 2019 (COVID-19) pandemic, prehospital and in-hospital emergency procedures faced unprecedented challenges, which might have caused a decline in the number of acute reperfusion therapy applied and led to a worsening of key quality measures for this treatment during lockdown. Methods: This prospective multicenter cohort study used data from the TRISP (Thrombolysis in Ischemic Stroke ... (read more)

DOI: 10.48350/157469